143 - Scientific Plenary
Prospective validation of pooled clinical prognostic factors in patients with recurrent and advanced cervical cancer: a Gynecologic Oncology Group (GOG) study
Tuesday, March 25, 2014: 11:20 AM
Ballroom B/C (Tampa Convention Center)
K. S. Tewari1, M. Sill2, B. J. Monk3, H. J. Long4, R. T. Penson5, H. Huang2, L. M. Landrum6, A. Oaknin7, H. Michael8, D. H. Moore9, M. M. Leitao10, L. M. Ramondetta11 and T. J. Reid12
1University of California at Irvine, Irvine, CA, 2Gynecologic Oncology Group Statistical and Data Center, Buffalo, NY, 3University of Arizona Cancer Center, Phoenix, AZ, 4Mayo Clinic, Rochester, MN, 5Massachusetts General Hospital/Harvard University, Boston, MA, 6The University of Oklahoma, Oklahoma City, OK, 7GEICO (Grupo Espanol de Investigacion en Cancer de Ovario), Barcelona, Spain, 8Indiana University School of Medicine, Indianapolis, IN, 9Franciscan Physician Network Gynecologic Oncology Specialists, Indianapolis, IN, 10Memorial Sloan Kettering Cancer Center, New York, NY, 11The University of Texas MD Anderson Cancer Center, Houston, TX, 12University of Cincinnati, Cincinnati, OH
